These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7559193)

  • 41. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
    Alves CF; Vitor RW
    Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
    Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of pyrimethamine and sulfadiazine on the intestinal development of Toxoplasma gondii in cats.
    Sheffield HG; Melton ML
    Am J Trop Med Hyg; 1976 May; 25(3):379-83. PubMed ID: 937628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro assessment of antimicrobial agents against Toxoplasma gondii.
    Harris C; Salgo MP; Tanowitz HB; Wittner M
    J Infect Dis; 1988 Jan; 157(1):14-22. PubMed ID: 3121760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rifabutin is active in murine models of toxoplasmosis.
    Araujo FG; Slifer T; Remington JS
    Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Mehlhorn H; Dankert W; Hartman PG; Then RL
    Parasitol Res; 1995; 81(4):296-301. PubMed ID: 7624286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii.
    Khan AA; Nasr M; Araujo FG
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2284-9. PubMed ID: 9736550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of roxithromycin against Toxoplasma gondii in murine models.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():69-74. PubMed ID: 3429388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
    Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
    Araujo FG; Suzuki Y; Remington JS
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X; Ke OY; Zhang Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
    Araujo FG; Prokocimer P; Lin T; Remington JS
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2454-7. PubMed ID: 1489188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zidovudine antagonizes the action of pyrimethamine in experimental infection with Toxoplasma gondii.
    Israelski DM; Tom C; Remington JS
    Antimicrob Agents Chemother; 1989 Jan; 33(1):30-4. PubMed ID: 2712547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
    Mack DG; McLeod R
    Antimicrob Agents Chemother; 1984 Jul; 26(1):26-30. PubMed ID: 6383209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of minocycline against Toxoplasma gondii infection in mice.
    Chang HR; Comte R; Piguet PF; Pechère JC
    J Antimicrob Chemother; 1991 May; 27(5):639-45. PubMed ID: 1885421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
    Lescano SA; Amato Neto V; Chieffi PP; Bezerra RC; Gakiya E; Ferreira CS; Braz LM
    Rev Soc Bras Med Trop; 2004; 37(6):460-2. PubMed ID: 15765594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of ketolides in combination with other drugs to treat experimental toxoplasmosis.
    Araujo FG; Khan AA; Bryskier A; Remington JS
    J Antimicrob Chemother; 1998 Nov; 42(5):665-7. PubMed ID: 9848454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L; Velasco O; Sotelo J
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.
    Meneceur P; Bouldouyre MA; Aubert D; Villena I; Menotti J; Sauvage V; Garin JF; Derouin F
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1269-77. PubMed ID: 18212105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.